Inclusion Criteria:
  -  Subject scheduled for total pancreatectomy or pancreaticoduodenectomy
  -  Informed consent signed prior to any study-related procedure
Exclusion Criteria:
  -  Known liver disease before total pancreatectomy or pancreaticoduodenectomy (excluding NAFLD)
  -  Severe co-morbid disease (besides from the indication for the pancreas surgery)
  -  Pregnancy
  -  Any condition that the investigator feels would interfere with the safety of the trial participation or the safety of the subject
  -  Metastatic disease
Percutaneous liver biopsy exclusion criteria (to be evaluated before last visit)
  -  MR spectroscopy demonstrating lipid content <2%
  -  Haemoglobin <6 mmol/L
  -  INR >1.5
  -  Trombocytes <40 Ã— 109/L
  -  Skin infection in area where biopsy will be sampled